- Home
- BMY vs LMT Comparison
BMY vs LMT Comparison
Compare BMY & LMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- LMT
- Stock Information
- Founded
- BMY 1887
- LMT 1912
- Country
- BMY United States
- LMT United States
- Employees
- BMY N/A
- LMT N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- LMT Military/Government/Technical
- Sector
- BMY Health Care
- LMT Industrials
- Exchange
- BMY Nasdaq
- LMT Nasdaq
- Market Cap
- BMY 120.5B
- LMT 105.1B
- IPO Year
- BMY N/A
- LMT N/A
- Fundamental
- Price
- BMY $63.15
- LMT $479.36
- Analyst Decision
- BMY Hold
- LMT Buy
- Analyst Count
- BMY 14
- LMT 12
- Target Price
- BMY $58.00
- LMT $550.50
- AVG Volume (30 Days)
- BMY 12.1M
- LMT 1.8M
- Earning Date
- BMY 04-24-2025
- LMT 04-22-2025
- Dividend Yield
- BMY 3.94%
- LMT 2.75%
- EPS Growth
- BMY N/A
- LMT N/A
- EPS
- BMY N/A
- LMT 22.31
- Revenue
- BMY $48,300,000,000.00
- LMT $71,043,000,000.00
- Revenue This Year
- BMY N/A
- LMT $5.73
- Revenue Next Year
- BMY N/A
- LMT $3.84
- P/E Ratio
- BMY N/A
- LMT $21.49
- Revenue Growth
- BMY 7.32
- LMT 5.14
- 52 Week Low
- BMY $39.35
- LMT $419.70
- 52 Week High
- BMY $63.11
- LMT $618.95
- Technical
- Relative Strength Index (RSI)
- BMY 72.11
- LMT 65.33
- Support Level
- BMY $59.03
- LMT $448.49
- Resistance Level
- BMY $60.69
- LMT $463.74
- Average True Range (ATR)
- BMY 1.57
- LMT 10.98
- MACD
- BMY 0.59
- LMT 5.72
- Stochastic Oscillator
- BMY 100.00
- LMT 78.37
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About LMT Lockheed Martin Corporation
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.